Ablation, Pericarditis and Pulmonary

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Ablation

Pericarditis

Pulmonary

Biosense Webster Submits Application to U.S. FDA Seeking Approval of the VARIPULSE Platform for the Treatment of Paroxysmal Atrial Fibrillation

DAIC

MARCH 28, 2024

The VARIPULSE Platform is comprised of the VARIPULSE Catheter, a fully integrated variable-loop multielectrode catheter; the TRUPULSE Generator, a pulsed field ablation (PFA) generator; and the CARTO 3 System VARIPULSE Software, which provides full integration with the world's leading 3D cardiac mapping system.

Atrial Fibrillation

Atrial Fibrillation AFIB Ablation Pulmonary

Pulsed Field Ablation Using Focal Contact Force–Sensing Catheters for Treatment of Atrial Fibrillation: 1-Year Outcomes of the ECLIPSE AF Study

Circulation: Arrhythmia and Electrophysiology

DECEMBER 19, 2024

BACKGROUND:Pulsed field ablation (PFA) is a promising treatment for atrial fibrillation. Patients with paroxysmal or persistent atrial fibrillation underwent pulmonary vein (PV) isolation under deep sedation or general anesthesia and returned for remapping at 90 days to evaluate chronic durability. paroxysmal, and 58.5%

Atrial Fibrillation

Atrial Fibrillation Ablation Arrhythmia Outcomes

Webinars

Bridging Innovation & Patient Care: The Growing Role of AI

MORE WEBINARS

Cardiovascular Update

Biosense Webster Submits Application to U.S. FDA Seeking Approval of the VARIPULSE Platform for the Treatment of Paroxysmal Atrial Fibrillation

Pulsed Field Ablation Using Focal Contact Force–Sensing Catheters for Treatment of Atrial Fibrillation: 1-Year Outcomes of the ECLIPSE AF Study

Webinars

Stay Connected